HOME >> MEDICINE >> NEWS
We weren't made to multitask

It's readily apparent that handling two things at once is much harder than handling one thing at a time. Spend too much time trying to juggle more than one objective and you'll end up wanting to get rid of all your goals besides sleeping. The question is, though, what makes it so hard to process two things at once?

Two theories try to explain this phenomenon: "passive queuing" and "active monitoring." The former says that information has to line up for a chance at being processed at some focal point of the brain, while the latter suggests that the brain can process two things at once it just needs to use a complicated mechanism to keep the two processes separate. Recent research from MIT points to the former as an explanation.

Yuhong Jiang, Rebecca Saxe and Nancy Kanwisher, in a study to be published in the June issue of Psychological Science, a journal of the American Psychological Society, examined the brain activity involved in multitasking. They gave people two simple tasks. Task one was identifying shapes, and for some subjects, task two was identifying letters, for others it was identifying colors. The subjects were forced to switch from one task to the other in either one and a half seconds or one tenth of a second. When they had to switch faster, subjects would take as much as twice as long to respond than when switching more slowly.

Using MRI technology, Jiang, Saxe and Kanwisher examined subjects' brain activity while performing these tasks. They observed no increase in the sort of activity that would be involved in keeping two thought processes separate when subjects had to switch faster. This suggests that there are no complicated mechanisms that allow people to perform two tasks at once. Instead, we have to perform the next task only after the last one is finished.


'"/>

Contact: Yuhong Jiang
yuhong@wjh.harvard.edu
Association for Psychological Science
7-Jun-2004


Page: 1

Related medicine news :

1. News briefs from the journal CHEST, March 2005
2. LA BioMed medical/research briefs March 2005
3. News briefs from the journal CHEST, February 2005
4. LA BioMed medical/research briefs January 2005
5. News briefs from the journal Chest, January 2005
6. LA BioMed Medical/Research briefs January 2005
7. News briefs from the Journal CHEST, December 2004
8. News briefs from the Journal CHEST, November 2004
9. LA BioMed research briefs
10. News briefs from the journal Chest, October 2004
11. News briefs from the journal CHEST, May 2004

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most award-winning sunscreen ... Fondo of Marin. For the second year in a row, cyclists will stay ... “We are thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to the La Gorce Country Club in Miami Beach to host its Swirl: ...
(Date:2/23/2017)... ... 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. ... Not to Hot,” which will begin airing on February 24, 2017. The show chronicles ... the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information ... National Institute for Health and Care Excellence (NICE) framework. The agreement ... Health Service (NHS) to search, order and purchase medical and healthcare-related content through ...
(Date:2/23/2017)... Colorado (PRWEB) , ... February 23, 2017 , ... ... Magazine, an exciting, new, interactive publication where generations converge and explore the world ... expand their worldview, Dialog Magazine enables readers to gain understanding, increase empathy, and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
(Date:2/23/2017)... LG Innotek hat heute die weltweit erste ... das 1,5-fache des 45-mW-Moduls der Konkurrenz. UV-C ... und 280 nm und eignet sich damit für Sterilisationsaufgaben. Es ... zerstört. Das Produkt von LG Innotek erzeugt UV-Strahlung im ... ...
(Date:2/23/2017)... 2017 Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet ... der südwestlichen chinesischen Provinz Guizhou, 2017 mit dem Angebot von ... an der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - ... ... ...
Breaking Medicine Technology:
Cached News: